Long-term pulmonal therapy of cystic fibrosis-patients with amitriptyline

Cellular Physiology and Biochemistry

Volumn 39, Issue 2, 2016, Pages 565-572

  Adams, Constantin ^a   Icheva, Vanya ^a   Deppisch, Caroline ^a   Lauer, Josefine ^a   Herrmann, Gloria ^a   Graepler Mainka, Ute ^a   Heyder, Susanne ^a   Gulbins, Erich ^b,c   Riethmueller, Joachim ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Amitriptyline; Ceramide; CFTR; Cystic fibrosis

Indexed keywords

AMITRIPTYLINE; CERAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BACTERIAL INFECTION; BODY WEIGHT; CONSTIPATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; DYSURIA; FEMALE; FORCED EXPIRATORY VOLUME; GLAUCOMA; HUMAN; IN VIVO STUDY; LONG QT SYNDROME; LONG TERM CARE; LOW DRUG DOSE; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG FUNCTION; LUNG WEIGHT; MALE; MUSCLE HYPOTONIA; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PANCREAS INSUFFICIENCY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREMOR; VERTIGO; WEIGHT GAIN; DRUG EFFECT; FOLLOW UP; LUNG; METABOLISM; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TIME FACTOR; YOUNG ADULT;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BODY WEIGHT; CERAMIDES; CLINICAL TRIALS, PHASE II AS TOPIC; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; YOUNG ADULT;

EID: 84978513536     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000445648     Document Type: Article

References (28)

1. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, Collins FS: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-1065.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
3. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
4. Boucher RC: Airway surface dehydration in CF: pathogenesis and therapy. Annu Rev Med 2007;58:157- 170.
5. CF Foundation, Patient Registry Annual Report 2013, Bethesda, Maryland, USA. https://www.cff. org/2013-CFF-Patient-Registry-Annual-Data-Report.pdf
6. Grothe J, Riethmüller J, Tschürtz SM, Raith M, Pynn CJ, Stoll D, Bernhard W: Plasma phosphatidylcholine alterations in cystic fibrosis patients: impaired metabolism and correlation with lung function and inflammation. Cell Physiol Biochem 2015;35:1437-1453.
7. Siegmann N, Worbs D, Effinger F, Bormann T, Gebhardt M, Ulrich M, Wermeling F, Müller-Hermelink E, Biedermann T, Tighe M, Edwards MJ, Caldwell C, Leadbetter E, Karlsson MC, Becker KA, Gulbins E, Döring G: Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis. Cell Physiol Biochem 2014;34:56-70.
8. Grassmé H, Carpinteiro A, Edwards MJ, Gulbins E, Becker KA: Regulation of the inflammasome by ceramide in cystic fibrosis lungs. Cell Physiol Biochem. 2014;34:45-55.
9. Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW, Weller M, Tümmler B, Lang F, Grassme H, Döring G, Gulbins E: Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nature Med 2008;14:382-391.
10. Valdivieso ÁG, Clauzure M, Massip-Copiz M, Santa-Coloma TA: The Chloride Anion Acts as a Second Messenger in Mammalian Cells -Modifying the Expression of Specific Genes. Cell Physiol Biochem 2016;38:49-64.
11. Hao Y, Cheung CS, Yip WC, Ko WH: Nobiletin Stimulates Chloride Secretion in Human Bronchial Epithelia via a cAMP/PKA-Dependent Pathway. Cell Physiol Biochem 2015;37:306-320.
12. Brodlie M, McKean MC, Johnson GE, Gray J, Fisher AJ, Corris PA, Lordan JL, Ward C: Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 2010;182:369-375.
13. Bodas M, Min T, Mazur S, Vij N: Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema. J Immunol 2010;186:602-613.
14. Bodas M, Min T, Vij N: Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury. Am J Physiol Lung Cell Mol Physiol 2011;300:L811-820.
15. Riethmueller J, Anthonysamy J, Serra E, Schwab M, Döring G, Gulbins E: Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis. Cell Physiol Biochem 2009;24:65-72.
16. Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, Döring G: Alveolar inflammation in cystic fibrosis. J Cyst Fibros 2010;9:217-227.
17. Pewzner-Jung Y, Tavakoli Tabazavareh S, Grassmé H, Becker KA, Japtok L, Steinmann J, Joseph T, Lang S, Tümmler B, Schuchman EH, Lentsch AB, Kleuser B, Edwards MJ, Futerman AH, Gulbins E: Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa. EMBO Mol Med 2014;6:1205-1214.
18. Becker KA, Riethmüller J, Lüth A, Döring G, Kleuser B, Gulbins, E: Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol 2010;42:716-724.
19. Becker KA, Tümmler B, Gulbins E, Grassmé H: Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death. Biochem Biophys Res Commun 2010;403:368-374.
20. Becker KA, Henry B, Ziobro R, Riethmüller J, Gulbins E: Lipids in cystic fibrosis. Expert Rev Respir Med 2011;5:527-535.
21. Hurwitz R, Ferlinz K, Sandhoff K: The tricyclic antidepressants desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler 1994;375:447-450.
22. Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, Gulbins E: Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Med Chem 2008;51:219-237.
23. Gulbins E, Palmada M, Reichel M, Lüth A, Böhmer C, Amato D, Müller CP, Tischbirek CH, Groemer TW, Tabatabai G, Becker KA, Tripal P, Staedtler S, Ackermann TF, van Brederode J, Alzheimer C, Weller M, Lang UE, Kleuser B, Grassmé H, Kornhuber J: Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nature Med 2013;19:934-938.
24. Nährlich L, Mainz JG, Adams C, Engel C, Herrmann G, Icheva V, Lauer J, Deppisch C, Wirth A, Unger K, Graepler-Mainka U, Hector A, Heyder S, Stern M, Döring G, Gulbins E, Riethmüller J: Therapy of CF-patients with Amitriptyline and Placebo -a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study. Cell Physiol Biochem 2013;24:65-72.
25. Kraemer R, Baldwin DN, Amman RA, Frey U, Gallati S: Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res 2006;7:138.
26. Parker AC, Pritchard P, Preston T, Smyth RL, Choonara I: Enhanced drug metabolism in young children with cystic fibrosis. Arch Dis Childhood 1997;77:239-241.
27. Grassmé H, Jendrossek V, Riehle A, von Kürthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E: Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nature Med 2003;9:322-330.
28. Zhang Y, Li X, Carpinteiro A, Gulbins E: Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis. J Immunol 2008;181:4247-4254.